Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

The only actual available "test" for Alzheimer’s disease in younger people would be to check someone's APOE 4 levels, which ...

Guwahati: In a significant advancement for yak genomic science, the first-ever chromosome-level genome of the Indian yak (Bos ...

First-ever chromosome-level genome of the Indian yak revolutionizes breeding, conservation, and understanding of this vital ...

Douglas A. Tremblay, MD, discusses the importance of quality-of-life data from treating patients with polycythemia vera with ...

With the clinical hold on the tab-cel application lifted, phase 2 and 3 trials of the T-cell immunotherapy in patients with ...

Researchers now say such behavior could increase the risk of the disease that contributes to the deaths of more than 120,000 ...

Atara Biotherapeutics continues to salami slice its head count, this time laying off 30% of what remains of the biopharma's ...

A new study links prolonged sedentary behavior to increased risk of cognitive decline and brain shrinkage associated with ...